Skip to main content
8 December 2019
Last updated:
Sunday 8 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Evernow Publishing Ltd Privacy Policy. Read more.

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Free featured article

Chiesi invests in carbon minimal inhaler

Sunday 8 December 2019
Country

Italy

Chiesi Farmaceutici SpA has pledged to invest €350 million over five years to bring a new formulation of inhaler for respiratory diseases to the market with the goal of reducing the carbon footprint of these devices. The company is believed to be the first in the pharmaceutical industry to publicly commit to a lower the carbon footprint for aerosol inhalers. It announced the plan at the United Nations Climate Change Conference on 4 December.

Read more

New long-term data for Yescarta

Sunday 8 December 2019
Country

United States

New long-term data for the cancer therapy Yescarta (axicabtagene ciloleucel) have shown that nearly half of patients treated with the cell-based gene therapy were alive three years after treatment. The long-term data were presented on 7 December at the American Society of Hematology meeting in the US, and are similar to outcome data reported in 2017.

Read more

Metrion and LifeArc extend collaboration

Sunday 8 December 2019
Country

United Kingdom

The UK medical charity LifeArc has extended a research collaboration with Metrion Biosciences Ltd with the goal of identifying new compounds for neurological diseases using Metrion’s ion channel drug discovery technology. The year-old collaboration is being extended for a further 12 months.

Read more

ImCheck raises $53 million for antibody development

Thursday 5 December 2019
Country

France

Read more

Launch of new gene therapy company

Tuesday 3 December 2019
Country

Germany

Read more

Kiadis changes course

Wednesday 27 November 2019
Country

Netherlands

Read more

Novartis to acquire The Medicines Company for $9.7 billion

Sunday 24 November 2019
Country

Switzerland

Read more

Tecentriq with Avastin improves survival in liver cancer

Sunday 24 November 2019
Country

Switzerland

Read more

GHO Capital raises €975 million

Saturday 23 November 2019
Country

United Kingdom

Read more

Roche to acquire Promedior

Sunday 17 November 2019
Country

Switzerland

Read more

Affimed closes US share offering

Thursday 14 November 2019
Country

Germany

Read more

WHO clears Ebola vaccine

Wednesday 13 November 2019
Country

United States

Read more

Evotec sees double-digit growth

Wednesday 13 November 2019
Country

Germany

Read more
Looking for more?

Visit our news section for more articles.

News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Relapse Vaccines: Going after the residual disease in cancer, By Erik Manting

RelapseVaccinesErikManting Nov-Dec 2019.pdf

Latest MedNous Issue Highlights

MedNous November-December 2019

Relapse Vaccines
Going after the residual
disease in cancer
By Erik Manting

RNA Epigenetics
A new field of medicine
By Oliver Rausch

Research Strategy
Ion channel drug discovery
By Marc Rogers

Treating endometriosis
Interview with Maarit Merla

Cell and Gene Therapy
The challenge of viral vector
manufacture
By Gabriel Festoc

Meeting Report
New regulation for Medtech

 

The latest MedNous journal. Subscribe to download.

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Jacques Biton joins supervisory board at Nosopharm
Sunday December 8 2019
Norman Baylor joins science board at Valneva
Sunday December 8 2019
Vectura appoints Will Downie as CEO
Sunday December 8 2019
Santhera appoints Dario Eklund as CEO
Sunday December 8 2019
Robin Bhattacherjee is new CEO at Actimed
Sunday December 8 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.